Multiple sclerosis drugs on every 2026 Alaska Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 9 stand-alone Part D plans in Alaska cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | Wellcare Classic$0.00/moS4802-096 | HealthSpring Assurance Rx$0.00/moS5617-227 | Humana Basic Rx Plan$0.00/moS5884-116 | Humana Value Rx Plan$10.60/moS5884-213 | Wellcare Value Script$19.70/moS4802-165 | AARP Medicare Rx Saver from UHC$53.20/moS5921-377 | SilverScript Choice$94.90/moS5601-068 | AARP Medicare Rx Preferred from UHC$100.20/moS5921-415 | Humana Premier Rx Plan$112.40/moS5884-180 |
|---|---|---|---|---|---|---|---|---|---|
| Kesimptaofatumumab | Not covered | Tier 5PA25%QL 1.6/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| teriflunomidegeneric Aubagio | Tier 5PA25%QL 30/30d | Tier 5PA25%QL 30/30d | Tier 4PA28%QL 30/30d | Tier 4PA33%QL 30/30d | Tier 5PA25%QL 30/30d | Not covered | Tier 5PA25%QL 30/30d | Tier 435%QL 30/30d | Tier 4PA50%QL 30/30d |
| dimethyl fumarategeneric Tecfidera | Tier 4PA28%QL 56/28d | Tier 4PA29%QL 14/30d | Not covered | Not covered | Tier 4PA40%QL 56/28d | Tier 433%QL 56/28d | Not covered | Tier 435%QL 56/28d | Tier 4PA50%QL 14/30d |
| Vumeritydiroximel fumarate | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| fingolimodgeneric Gilenya | Tier 5PA25%QL 30/30d | Not covered | Tier 3PA24%QL 30/30d | Tier 3PA20%QL 30/30d | Tier 5PA25%QL 30/30d | Tier 433%QL 30/30d | Tier 5PA25%QL 30/30d | Tier 435%QL 30/30d | Tier 3PA$45.00QL 30/30d |
| Mayzentsiponimod | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Zeposiaozanimod | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Mavencladcladribine | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.